文献速递消化道肿瘤与早癌

多队列分析揭示不同人群结直肠癌粪便样本中古菌的改变

Multi-Cohort Analysis Reveals Altered Archaea in Colorectal Cancer Fecal Samples Across Populations.
PubMed 文献 · Gastroenterology · 2024-10-28

该研究纳入7个国家10个独立队列及一个内部队列共2101份粪便宏基因组(748例结直肠癌、471例腺瘤、882例健康对照),分析古菌群落改变及其与细菌的相互作用。结果发现结直肠癌患者中甲烷杆菌门富集而甲烷 Massiliicoccales 目耗竭,多个物种在健康-腺瘤-结直肠癌序列中呈进行性减少;古菌与细菌标志物联合模型在留一队列交叉验证中区分结直肠癌与健康人的曲线下面积为0.744至0.931。

要点

  • 结直肠癌患者粪便古菌α多样性和组成从健康对照、腺瘤到结直肠癌发生改变
  • Methanobrevibacter_A smithii等富集,Methanosphaera stadtmanae等8个物种在结直肠癌中耗竭
  • 古菌与细菌标志物联合模型优于单界模型,AUC为0.744至0.931

核心结论

  • 多队列分析揭示健康人、腺瘤患者和结直肠癌患者肠道古菌及其与细菌相互作用存在显著改变
  • 古菌标志物联合细菌特征有潜力作为结直肠癌无创诊断标志物

研究设计与样本

  • 研究纳入7个国家10个独立队列的粪便宏基因组数据及一个内部队列,共2101份宏基因组(748例结直肠癌、471例腺瘤、882例健康对照)
  • 使用Kraken2对照基因组分类数据库进行物种分类分析,并采用随机森林模型识别多队列诊断微生物标志物

主要发现

  • 古菌α多样性从健康对照、腺瘤患者到结直肠癌患者发生改变,甲烷杆菌门富集而甲烷 Massiliicoccales 目耗竭
  • 在多个队列中,结直肠癌患者 Methanobrevibacter_A smithii 和 Methanobrevibacter_A sp002496065 富集,包括 Methanosphaera stadtmanae 和 Methanomassiliicoccus_A intestinalis 在内的8个物种耗竭
  • M stadtmanae、Methanobrevibacter_A sp900314695 和 Methanocorpusculum sp001940805 在健康-腺瘤-结直肠癌序列中呈进行性减少
  • 结直肠癌中耗竭的产甲烷古菌与产丁酸菌共现相互作用增强,产甲烷相关基因和通路在结直肠癌患者中富集
  • 包含古菌和细菌标志物的模型在留一队列交叉验证中区分结直肠癌与健康人的曲线下面积为0.744至0.931,优于单界模型

临床怎么用

  • 原文结论指出古菌标志物联合细菌特征有潜力作为结直肠癌的无创诊断标志物

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Archaea are important components of the host microbiome, but their roles in colorectal cancer (CRC) remain largely unclear. We aimed to elucidate the contribution of gut archaea to CRC across multiple populations. METHODS: This study incorporated fecal metagenomic data from 10 independent cohorts across 7 countries and an additional in-house cohort, totaling 2101 metagenomes (748 CRC, 471 adenoma, and 882 healthy controls [HCs]). Taxonomic profiling was performed using Kraken2 against the Genome Taxonomy Database. Alterations of archaeal communities and their interactions with bacteria, as well as methanogenic functions were analyzed. A Random Forest model was used to identify multicohort diagnostic microbial biomarkers in CRC. RESULTS: The overall archaeal alpha diversity shifted from HCs, patients with adenoma, to patients with CRC with the Methanobacteriota phylum enriched while the order Methanomassiliicoccales depleted. At the species level, Methanobrevibacter_A smithii and Methanobrevibacter_A sp002496065 were enriched, whereas 8 species, including Methanosphaera stadtmanae and Methanomassiliicoccus_A intestinalis, were depleted in patients with CRC across multiple cohorts. Among them, M stadtmanae, Methanobrevibacter_A sp900314695, and Methanocorpusculum sp001940805 exhibited a progressive decrease in the HC-adenoma-CRC sequence. CRC-depleted methanogenic archaea exhibited enhanced co-occurring interactions with butyrate-producing bacteria. Consistently, methanogenesis-related genes and pathways were enriched in patients with CRC. A model incorporating archaeal and bacterial biomarkers outperformed single-kingdom models in discriminating patients with CRC from healthy individuals with the area under the curve ranging from 0.744 to 0.931 in leave-one-cohort-out analysis. CONCLUSIONS: This multicohort analysis uncovered significant alterations in gut archaea and their interactions with bacteria in healthy individuals, patients with adenoma, and patients with CRC. Archaeal biomarkers, combined with bacterial features, have potential as noninvasive diagnostic biomarkers for CRC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Li T, Coker OO, Sun Y, et al. Multi-Cohort Analysis Reveals Altered Archaea in Colorectal Cancer Fecal Samples Across Populations. Gastroenterology. 2024. PMID: 39490771. doi:10.1053/j.gastro.2024.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。